The manufacturer recommends stopping Ozempic at least two months before attempting to conceive
With a 15% bulk discount on orders of five or more vials, the per-vial cost drops to $153 a saving of $135 on a five-vial order ($900 down to $765)
Apart from monetary considerations, many patients are choosing Wegovy for several other reasons: Heart health advantages: Wegovy is uniquely approved for lowering the likelihood of major cardiovascular events in people with existing heart disease, even if they do not lose substantial weight
However, for those with a BMI 40 or BMI 35 with obesity-related comorbidities, GLP-1 agonists alone often do not provide the degree of weight loss required for disease control or resolution
Additionally, insurance coverage for new drugs typically lags by 612 months after approval
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and manage chronic weight in adults with obesity